0001225208-22-006813.txt : 20220510 0001225208-22-006813.hdr.sgml : 20220510 20220510205429 ACCESSION NUMBER: 0001225208-22-006813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220507 FILED AS OF DATE: 20220510 DATE AS OF CHANGE: 20220510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chopra Daveen CENTRAL INDEX KEY: 0001740963 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 22911782 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2022-05-07 0001099800 Edwards Lifesciences Corp EW 0001740963 Chopra Daveen ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Surgical Structural Heart Common Stock 2022-05-07 4 F 0 305.0000 100.5200 D 18493.0000 D Common Stock 2022-05-08 4 M 0 8531.0000 0 A 27024.0000 D Common Stock 2022-05-08 4 F 0 4469.0000 100.5200 D 22555.0000 D Performance Rights 2022-05-08 4 M 0 8531.0000 100.5200 D 2022-05-08 2026-05-07 Common Stock 8531.0000 10968.0000 D On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2022-05-10